MSC for Occlusive Disease of the Kidney

Renovascular Hypertension Clinical Trial

Official title:
Phase I Study of Autologous Mesenchymal Stem Cells in the Treatment of Atherosclerotic Renal Artery Stenosis

Status Completed

Clinical Trial Summary

To determine the safety and toxicity of intra-arterial infused autologous adipose derived mesenchymal stromal (stem) cells in patients with vascular occlusive disease of the kidney.

Clinical Trial Description

Individuals with unilateral arterial occlusive disease will be treated to injured kidney with autologous cells. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01840540
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Completed
Phase	Phase 1
Start date	April 2013
Completion date	April 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT00868972` - Renal Stenting With Distal Atheroembolic Protection	Phase 2/Phase 3
Recruiting	`NCT05834803` - Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.	N/A
Completed	`NCT00006173` - Magnetic Resonance Imaging for Evaluating Kidney Function	N/A